# Palm Kernel Oil (Elaeis guineensis)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/palm-kernel-oil
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 2 / 10
**Category:** Seed Oils
**Also Known As:** Elaeis guineensis kernel oil, PKO, Palm seed oil, African oil palm kernel oil, Dende kernel oil, White palm oil, Lauric oil from palm

## Overview

Palm kernel oil, derived from the seeds of Elaeis guineensis, is rich in medium-chain saturated fatty acids—primarily lauric acid (48%) and myristic acid (16%)—which are rapidly metabolized via hepatic beta-oxidation rather than stored as adipose tissue. Its high lauric acid content confers surfactant properties exploited in nanoemulsion drug delivery systems, improving absorption of lipophilic bioactive compounds by reducing droplet size to 30–35 nm.

## Health Benefits

• Enhanced delivery of nutrients and compounds - forms nanoemulsions (30-35 nm droplets) improving absorption of lipophilic substances (preliminary evidence from formulation studies)
• Potential [cardiovascular](/ingredients/condition/heart-health) neutrality - animal feeding studies up to 34.6 g/kg dry matter showed no adverse effects (preliminary evidence)
• Skin permeation enhancement - demonstrated 51% in vitro release through artificial membranes when used in formulations (preliminary evidence)
• Formulation stability - provides thermal and colloidal stability for supplement delivery systems (preliminary evidence)
• Medium-chain triglyceride source - contains ~50% lauric acid which may support [energy metabolism](/ingredients/condition/energy) (traditional use, no clinical evidence)

## Mechanism of Action

Lauric acid (C12:0) in palm kernel oil is absorbed via portal circulation and rapidly transported to the liver, where it undergoes beta-oxidation to produce ketone bodies and acetyl-CoA, bypassing the lymphatic chylomicron pathway typical of long-chain fatty acids. Lauric acid also inhibits bacterial lipopolysaccharide (LPS)-induced NF-κB signaling at the TLR4 receptor level, potentially modulating [inflammatory](/ingredients/condition/inflammation) cytokine cascades. When formulated as nanoemulsions (30–35 nm droplets), the oil's surfactant-active fatty acids solubilize lipophilic compounds within mixed micelles, enhancing transcellular absorption across intestinal epithelial cells via passive diffusion.

## Clinical Summary

Animal feeding studies using palm kernel oil up to 34.6 g/kg dry matter demonstrated no statistically significant adverse effects on serum lipid profiles or [cardiovascular](/ingredients/condition/heart-health) biomarkers, suggesting metabolic neutrality at moderate intakes. Human clinical data specific to palm kernel oil supplementation remains sparse; most evidence is extrapolated from coconut oil trials (which share similar lauric acid content ~48%) involving 40–100 participants showing modest HDL elevation. Nanoemulsion formulation studies—primarily in vitro and rodent models—show enhanced bioavailability of co-administered lipophilic compounds, though controlled human pharmacokinetic trials are lacking. The current evidence base is preliminary, relying heavily on formulation research and animal models, warranting caution before drawing definitive efficacy conclusions.

## Nutritional Profile

{"macronutrients": {"total_fat": "100g per 100g", "saturated_fat": "81g per 100g", "monounsaturated_fat": "11g per 100g", "polyunsaturated_fat": "1.5g per 100g"}, "micronutrients": {"vitamin_E": "15mg per 100g", "vitamin_K": "24\u00b5g per 100g"}, "bioactive_compounds": {"tocotrienols": "800mg per 100g", "carotenoids": "500\u00b5g per 100g"}, "bioavailability_notes": "The high fat content enhances the absorption of fat-soluble vitamins and bioactive compounds, such as tocotrienols and carotenoids."}

## Dosage & Preparation

No clinically studied dosage ranges for palm kernel oil in humans have been established. Animal studies used dietary inclusions of 0-34.6 g/kg dry matter (up to 5.2% in diets) without adverse effects. Formulation studies used palm kernel oil esters at variable percentages as a delivery base. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Palm kernel oil is generally recognized as safe (GRAS) for food use, but its high saturated fat content (~82%) may raise [LDL cholesterol](/ingredients/condition/heart-health) with chronic high-dose supplementation, particularly in individuals with familial hypercholesterolemia or pre-existing dyslipidemia. No established drug interactions are documented, though its lauric acid content may theoretically enhance absorption of lipophilic drugs (e.g., fat-soluble statins, vitamin D, curcumin) when co-administered, potentially altering therapeutic dosing thresholds. Pregnancy safety at supplemental doses has not been specifically studied; dietary amounts from food are considered acceptable, but high-dose supplemental use is not recommended during pregnancy or lactation due to insufficient data. Individuals on anticoagulants or lipid-lowering medications (statins, fibrates) should consult a healthcare provider before using palm kernel oil supplements due to theoretical lipid-modifying interactions.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on palm kernel oil were identified in available research. Evidence is limited to animal models showing safety at dietary inclusions up to 34.6 g/kg dry matter and in vitro formulation studies demonstrating enhanced delivery properties. A systematic review of 9 animal studies on related palm oil (not kernel oil) found lipid-lowering effects, but excluded palm kernel oil due to different composition.

## Historical & Cultural Context

No historical or traditional medicinal uses of palm kernel oil were documented in available sources. The oil is primarily noted for industrial and food applications rather than ethnomedicinal contexts.

## Synergistic Combinations

Fat-soluble vitamins (A, D, E, K), CoQ10, curcumin, CBD, omega-3 fatty acids

## Frequently Asked Questions

### What is the lauric acid content of palm kernel oil compared to coconut oil?

Palm kernel oil contains approximately 48% lauric acid (C12:0) by fatty acid composition, nearly identical to coconut oil's 45–52% lauric acid content. Both oils are among the richest dietary sources of lauric acid, distinguishing them from other vegetable oils like olive or sunflower oil, which contain less than 1% lauric acid.

### Can palm kernel oil improve nutrient absorption as a supplement?

Preliminary formulation studies show that palm kernel oil can be processed into nanoemulsions with droplet sizes of 30–35 nm, which significantly improves the solubilization and intestinal absorption of lipophilic compounds such as fat-soluble vitamins (A, D, E, K) and phytochemicals like curcumin. This effect is attributed to the surfactant properties of its medium-chain fatty acids forming stable mixed micelles in the gut. However, these findings are primarily from in vitro and animal models, with no confirmed human clinical trials yet published.

### Is palm kernel oil bad for your heart?

Animal feeding studies up to 34.6 g/kg dry matter found no adverse cardiovascular effects from palm kernel oil consumption, suggesting metabolic neutrality at moderate doses. However, its ~82% saturated fat content raises theoretical concerns about LDL cholesterol elevation with sustained high-dose supplemental intake, a risk well-documented for saturated fats generally. Current evidence does not confirm palm kernel oil as harmful at dietary doses, but long-term high-dose human cardiovascular trials have not been conducted.

### What is the difference between palm oil and palm kernel oil?

Palm oil is extracted from the fleshy mesocarp (fruit pulp) of the Elaeis guineensis palm and is rich in palmitic acid (C16:0, ~44%) and oleic acid (C18:1, ~39%), along with high concentrations of tocotrienols and beta-carotene. Palm kernel oil, extracted from the inner seed, contains a completely different fatty acid profile dominated by lauric acid (~48%) and myristic acid (~16%), resembling coconut oil more than palm fruit oil. These compositional differences result in distinct metabolic pathways, functional properties, and supplement applications.

### What dose of palm kernel oil is used in supplements or research?

No standardized human supplemental dosage for palm kernel oil has been established, as most research has been conducted in animal models or in vitro formulation studies. Animal studies showing cardiovascular neutrality used doses equivalent to 34.6 g/kg dry matter of diet, which does not directly translate to human dosing. In nanoemulsion delivery systems, palm kernel oil is typically used as a carrier oil at concentrations of 5–20% w/w within formulations rather than as a standalone supplement, and clinical human dose-ranging studies have not yet been published.

### Does palm kernel oil enhance the absorption of fat-soluble vitamins like A, D, E, and K?

Palm kernel oil can potentially improve absorption of fat-soluble vitamins due to its ability to form nanoemulsions (30-35 nm droplets) that enhance the bioavailability of lipophilic compounds. This property makes it useful as a delivery matrix in supplement formulations, though most evidence comes from preliminary formulation studies rather than human clinical trials. The specific absorption enhancement depends on the vitamin type and the supplement formulation design.

### How does palm kernel oil compare to other MCT oils for supplement formulations?

Palm kernel oil contains approximately 50% lauric acid, making it higher in medium-chain triglycerides compared to fractionated coconut oil, which allows for better nanoemulsion formation and nutrient delivery enhancement. Unlike purely synthetic MCT oils, palm kernel oil provides a natural source with demonstrated skin permeation and absorption-enhancing properties in preliminary studies. The choice between them depends on whether the goal is nutrient delivery optimization versus pure MCT supplementation.

### What is the evidence for palm kernel oil's safety in long-term supplement use?

Animal feeding studies have demonstrated safety at doses up to 34.6 g/kg dry matter without adverse cardiovascular effects, suggesting potential safety for chronic use in supplemental amounts. However, most evidence in humans remains limited to short-term studies and formulation research rather than long-term supplementation trials. Clinical data specifically evaluating safety profiles in vulnerable populations such as children, pregnant women, or those with existing health conditions remains preliminary.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*